Efficacy and Safety of Intracavernosal Alprostadil in Diabetic Patients with Erectile Dysfunction
Erectile dysfunction is a common complication of Diabetes Mellitus. Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has been used successfully in the treatment of erectile dysfunction. Results with Alprostadil have shown a poorer response, shorter duration of actio...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2001
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/36699/1/DR_SANJAY_LALITCHANDRA_DOSHI.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Erectile dysfunction is a common complication of Diabetes Mellitus.
Intracavernosal Alprostadil, the naturally occurring form of Prostaglandin E 1, has
been used successfully in the treatment of erectile dysfunction. Results with
Alprostadil have shown a poorer response, shorter duration of action and need
for higher dosage in diabetic patients with erectile dysfunction when compared
to the general population. No study targeted specifically to the diabetic
population has been completed with Alprostadil so far. |
|---|